FDA Inspection 1191880 — Padagis Israel Pharmaceuticals Ltd.
The FDA completed an inspection of Padagis Israel Pharmaceuticals Ltd. on Oct 27, 2022 in Yerucham. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 27, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Yerucham (Israel)